Immunolab (India) Private Limited
About Immunolab (India) Private Limited
Data last updated:
Immunolab (India) Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 07 March 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PTC066079.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.64 Lakh. It is led by directors including Aditya Kohli and Vinod Kohli.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 203 Swastik Bhawan Ranjeet Nagar Commercial Complex, New Delhi, Delhi, India – 110008.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.71 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹2.9 Lakh (net margin 29.8%) and EBITDA of ₹3.39 Lakh (EBITDA margin 34.9%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Immunolab (India) Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address203 Swastik Bhawan Ranjeet Nagar Commercial Complex, New Delhi, Delhi, India – 110008
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Immunolab (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Immunolab (India) is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Immunolab (India) Private Limited, buy the company report.
Financials of Immunolab (India) Private Limited
FY 2025 filings availableImmunolab (India) Private Limited reported revenue of ₹9.71 Lakh (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 12%. EBITDA rose 127% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.9 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 34.9% | ||||
| Net Profit Margin | 29.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Immunolab (India) Private Limited, buy the company report.
Board of directors of Immunolab (India) Private Limited
Immunolab (India) has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Kohli Also directs: Techno Buildwell Private Limited, P R Holdings Limited, Life Plus Medical India Private Limited and 2 more | Director | 30 Sep 2008 | 18 Years 1 Months | Current |
| Vinod Kohli Also directs: Techno Buildwell Private Limited, Life Plus Medical India Private Limited, Alliedmed Manufacturing Private Limited and 1 more | Director | 07 Mar 1995 | 31 Years 7 Months | Current |
| Akhil Kohli Also directs: Techno Buildwell Private Limited, Life Plus Medical India Private Limited, Alliedmed Manufacturing Private Limited and 1 more | Director | 30 Sep 2008 | 18 Years 1 Months | Current |
| Anita Kohli | Director | 07 Mar 1995 | 31 Years 7 Months | Current |
Peer comparison
Immunolab (India) Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Treat in India Healthcare Private Limited | ₹9.83 Lakh (FY 2024) | -9.0% | Bawana Dsiidc, Delhi, India | |||
| Blacksteed Hospitality and Foods Private Limited | ₹9.82 Lakh (FY 2024) | Gurgaon, Haryana, India | ||||
| Dr. Jessy Memorial Hospital Private Limited | ₹9.8 Lakh (FY 2024) | Kottarakkara, Kerala, India | ||||
| Secure Dental Care & Cure Private Limited | ₹9.77 Lakh (FY 2025) | 73.0% | Chandrapur, Maharashtra, India | |||
| Pushpveda Medtech Private Limited | ₹9.74 Lakh (FY 2025) | 125.0% | Delhi, India | |||
| Immunolab (India) Private Limitedthis company | ₹9.71 Lakh (FY 2025) | ₹2.9 Lakh | 29.8% | 4.0% | New Delhi, Delhi, India | |
| Medicrest Lifesciences Private Limited | ₹9.7 Lakh (FY 2024) | 1707.0% | Noida, Uttar Pradesh, India | |||
| Mei Traditional Fitness (OPC) Private Limited | ₹9.65 Lakh (FY 2025) | 23.0% | Salem, Tamil Nadu, India | |||
| D'mans Enterprises (Beeramguda) Private Limited | ₹9.65 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| S2p Health Care Private Limited | ₹9.64 Lakh (FY 2025) | 16.0% | New Delhi, Delhi, India | |||
| Samvedivf Private Limited | ₹9.62 Lakh (FY 2025) | Vadodara, Gujarat, India |
To see the full peer comparison of Immunolab (India) Private Limited, buy the company report.
Auditor
Immunolab (India) Private Limited is audited by P.N. KHANNA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.N. KHANNA & CO. | FY 2017 | 02252N |
Shareholding
The shareholding of Immunolab (India) Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Immunolab (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Immunolab (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Immunolab (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Immunolab (India) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Immunolab (India) Private Limited has 4 board changes on record since 1995: 4 appointments. The latest: Aditya Kohli was appointed as Director on 30 Sep 2008.
Frequently asked questions
Immunolab (India) is an active private limited company based in New Delhi, Delhi, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 07 March 1995 (31+ years old) and is registered under CIN U74899DL1995PTC066079.
Immunolab (India) has 4 current directors:
- Aditya Kohli - Director
- Vinod Kohli - Director
- Akhil Kohli - Director
- Anita Kohli - Director
The latest financial statements of Immunolab (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Immunolab (India) is U74899DL1995PTC066079. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Immunolab (India) was incorporated on 07 March 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Immunolab (India) by revenue are Treat in India Healthcare Private Limited, Blacksteed Hospitality and Foods Private Limited, Dr. Jessy Memorial Hospital Private Limited, Secure Dental Care & Cure Private Limited, Pushpveda Medtech Private Limited and 5 more, all in the same principal business activity (human health activities).
Aditya Kohli was appointed as Director on 30 Sep 2008. Akhil Kohli was appointed as Director on 30 Sep 2008. Anita Kohli was appointed as Director on 07 Mar 1995. Immunolab (India) has 4 board changes on record in total.
The registered office of Immunolab (India) is at 203 Swastik Bhawan Ranjeet Nagar Commercial Complex, New Delhi, Delhi, India – 110008.
Immunolab (India) operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Immunolab (India) is compliant as of 10 July 2026. The company is actively filing with the Registrar of Companies.
Immunolab (India) can be reached at its registered office: 203 Swastik Bhawan Ranjeet Nagar Commercial Complex, New Delhi, Delhi, India – 110008.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
